Publications by authors named "Pascal Merlet"

Claim this Profile
P
Patterns of metabolic response in patients receiving commercial CAR T-cells for relapsing/refractory aggressive B cells lymphoma.
Laetitia Vercellino, Siham Betterki, Estelle Blanc, Eric de Kerviler, Caterina Cristinelli, Pascal Merlet

Br J Radiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors.
Alexia Rivas, Julie Delyon, Antoine Martineau, Estelle Blanc, Clara Allayous, Pascal Merlet

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Extensive Analysis of F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis.
Nicolas Louarn, Lionel Galicier, Rémi Bertinchamp, David Lussato, Françoise Montravers, Pascal Merlet

J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma.
Louise Pesqué, Julie Delyon, Coralie Lheure, Barouyr Baroudjian, Maxime Battistella, Pascal Merlet

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.
Laetitia Vercellino, Dorine de Jong, Laurent Dercle, Benoit Hosten, Brian Braumuller, Pascal Merlet

Diagnostics (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Pascal Merlet

Blood Adv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma.
Coralie Reger de Moura, Laetitia Vercellino, Fanélie Jouenne, Barouyr Baroudjian, Aurélie Sadoux, Pascal Merlet

Transl Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.
Patricia de Cremoux, Lucie Biard, Brigitte Poirot, Philippe Bertheau, Luis Teixeira, Pascal Merlet

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of F-FLT PET.
Laetitia Vercellino, Matthieu John Ouvrier, Emmanuelle Barré, Bruno Cassinat, Virginie de Beco, Pascal Merlet

J Nucl Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
Charles Lemarignier, Antoine Martineau, Luis Teixeira, Laetitia Vercellino, Marc Espié, Pascal Merlet

Eur J Nucl Med Mol Imaging· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.
David Groheux, Antoine Martineau, Luis Teixeira, Marc Espié, Patricia de Cremoux, Pascal Merlet

Breast Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases.
Nathalie Rizzo-Padoin, Michael Chaussard, Nicolas Vignal, Ewa Kotula, Vadim Tsoupko-Sitnikov, Pascal Merlet

Nucl Med Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
David Groheux, Lucie Biard, Sylvie Giacchetti, Luis Teixeira, Elif Hindié, Pascal Merlet

J Nucl Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion.
Caroline Gorin, Gael Y Rochefort, Rumeyza Bascetin, Hanru Ying, Julie Lesieur, Pascal Merlet

Stem Cells Transl Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
David Groheux, Mohamed Majdoub, Alice Sanna, Patricia de Cremoux, Elif Hindié, Pascal Merlet

Radiology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer.
Laurent Quero, Laetitia Vercellino, Eric de Kerviler, Pierre Mongiat-Artus, Stephane Culine, Pascal Merlet

Clin Nucl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
David Groheux, Mohamed Majdoub, Florent Tixier, Catherine Cheze Le Rest, Antoine Martineau, Pascal Merlet

Eur J Nucl Med Mol Imaging· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
David Groheux, Alice Sanna, Mohamed Majdoub, Patricia de Cremoux, Sylvie Giacchetti, Pascal Merlet

J Nucl Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "18F-Choline PET-CT in the Management of Lung Cancer and Mucinous Tumors?".
Jérémie Calais, David Lussato, Pascal Merlet

J Thorac Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast infiltration by relapsed acute lymphoblastic leukaemia on FDG PET/CT.
Anna Luzurier, Axel Van Der Gucht, Estelle Blanc, Etienne Lengline, David Groheux, Pascal Merlet

Eur J Nucl Med Mol Imaging· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of a solitary pulmonary metastasis from prostatic Adenocarcinoma misdiagnosed as a Bronchocele: usefulness of 18F-choline and 18F-FDG PET/CT.
Jérémie Calais, David Lussato, Jean Menard, Eric De Kerviler, Pierre Mongiat-Artus, Pascal Merlet

J Thorac Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.
Jean François Grellier, Laetitia Vercellino, Thierry Leblanc, Pascal Merlet, Catherine Thieblemont

Eur J Nucl Med Mol Imaging· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
David Groheux, Elif Hindié, Michel Marty, Marc Espié, Domenico Rubello, Pascal Merlet

Eur J Radiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
David Groheux, Elif Hindié, Sylvie Giacchetti, Anne-Sophie Hamy, Frederique Berger, Pascal Merlet

Eur J Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of SPECT/CT in sentinel lymph node detection in patients with breast cancer.
Laetitia Vercellino, Jessica Ohnona, David Groheux, Abdelhak Slama, Patrick M Colletti, Pascal Merlet

Clin Nucl Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis